Full Papers
recommended medium and temperature conditions. After cultiva-
tion, cells were harvested by centrifugation at 10000g for 30 min
at 48C. Isolated cells were resuspended in potassium phosphate
buffer (50 mm, pH 7) at a ratio of 1 g (wet weight) of cells per 3 mL
of buffer. Glass beads (ø 0.25–0.50 mm, 1.2 g) were added to a cell
suspension (600 mL). Cells were disrupted (with cooling) at 30 Hz
for 15 min with a mixer mill from Retsch (Haan, Germany). The
crude extract was obtained after centrifugation at 20000g for
Molecular cloning of the alcohol dehydrogenase gene of
PPADH: Genomic DNA isolated from P. pastoris GS115 was used as
template for amplification of the putative dihydrokaempferol 4-re-
ductase with the following primers: 5’-GCG CTT CCA TAT G GTT
TCT AAG G-3’ and 5’-CGG CTC GAG ATT ATT TAT TAG CAC GC-3’
cloned with an N-terminal His-tag (in pET28a, Novagen (Merck))
with recognition sites for NdeI and XhoI. The PCR product was
cloned into pET28a (Novagen) between the NdeI and XhoI restric-
tion sites by standard techniques. To investigate the effects of His-
tags on activity, additional constructs 1) without a His-tag, 2) with
a C-terminal His-tag, and 3) with both N- and C-terminal His-tags
were created by QuikChange PCR.
3
0 min at 48C.
Screening assay for the reduction of the CF -ketone 1: The isolat-
3
ed crude extracts, in combination with an in situ cofactor regenera-
tion system consisting of d-glucose and GDH, were tested for the
Heterologous expression of PPADH: For recombinant protein ex-
pression, E. coli BL21(DE3) cells containing the recombinant plas-
reduction of the CF -ketone. The assay mixture, with a total
3
+
volume of 1 mL, contained crude extract (200 mL), NAD and
NADP (1 mm), potassium phosphate buffer (pH 7.5, 50 mm),
+
mid were cultivated overnight at 378C in lysogeny broth (LB;
À1
1
0 mL) containing kanamycin (50 mgmL ). For expression in coni-
MgCl2 (1 mm), d-glucose (100 mm) and racemic CF -ketone
3
cal flasks, a final cell concentration of 0.05 optical density at
600 nm (OD600) was used to inoculate different amounts of Terrific
Broth (TB) medium containing the corresponding antibiotic for se-
lection. The cultures were cultivated at 378C. At an OD600 of 0.5 to
(
10 mm) as substrate. For cofactor regeneration, GDH from Bacillus
À1
subtilis (ꢀ5 Uml ) was used. The reaction mixture was shaken at
9
00 rpm at 308C overnight (20 h). Reduction of the CF -ketone was
3
examined by GC analysis. For this purpose, samples (100 mL) were
mixed with ethyl acetate (200 mL) for extraction and centrifuged.
0
.7 the production of the recombinant ADH was induced by addi-
tion of isopropyl-b-d-thiogalactopyranoside (IPTG) to a final con-
centration of 0.5 mm. For the determination of the optimal growth
conditions cultures were grown after induction at 20, 24, 30, and
Cultivation of Pichia pastoris GS115, cell disruption, and purifica-
tion of the alcohol dehydrogenase: The strain Pichia pastoris
GS115 was kindly provided by the research group of Prof. Joachim
Ernst (University of Dusseldorf) and was grown in YPD medium at
3
78C and assayed after a period of 20 h.
Purification of recombinant PPADH: The bacterial culture was har-
vested by centrifugation (18000g, 30 min, 48C). A cell suspension
2
58C for three days. After harvesting by centrifugation, the Pichia
cells were resuspended in potassium phosphate buffer (50 mm,
pH 7) at a ratio of 1 g (wet weight) of cells per 3 mL of buffer. The
cell suspension was disrupted with a French Press Cell Disrupter
(25%) in Tris·HCl buffer (pH 7.0, 100 mm) was prepared and dis-
rupted by sonication on ice (2 min, 25% power output, 1 min cool-
ing, three cycles in total). After a centrifugation step (17000g,
(
Glen Mills, Inc., Clifton, NJ, USA) three times at 900 psi with cool-
3
0 min, 48C), the cleared crude extract was used for protein purifi-
ing steps in between. The crude extract was obtained after centri-
fugation (20000g for 45 min at 48C) and used for the ammonium
sulfate precipitation. Firstly, ammonium sulfate was added to the
crude extract to produce a final concentration of 2.47m with
gentle stirring on ice for 1 h and a subsequent centrifugation step
to remove a proportion of the Pichia crude extract proteins. The re-
sulting supernatant was subjected to a second ammonium sulfate
precipitation by addition of ammonium sulfate to a final concen-
tration of 4.25m under the same conditions as described previous-
ly. After centrifugation the supernatant was removed, and the re-
sulting sediment was resuspended in the initial volume with start
buffer [potassium phosphate buffer (100 mm)+ammonium sulfate
cation by immobilized metal affinity chromatography (IMAC, Ni-
NTA, MCLAB, Nimagen, Netherlands). The column was equilibrated
with lysis buffer [NaH PO4 (50 mm), NaCl (300 mm), imidazole
2
(10 mm), pH 8.0]. After loading, unbound proteins were eluted
with wash buffer [NaH PO4 (50 mm), NaCl (300 mm), imidazole
2
(20 mm), pH 8.0]. The PPADH was obtained with an imidazole con-
centration of 250 mm [NaH PO (50 mm), NaCl (300 mm), imidazole
2
4
(250 mm), pH 8.0]. After a desalting step with PD-10 columns (Se-
phadex G 25, GE Healthcare), the purified enzyme was stored in
Tris·HCl buffer (pH 7.0, 100 mm) at 48C prior to use.
Activity assay: A continuous assay with use of UV absorbance at
(
pH 7.2, 1.7m)], and the solution was applied to a Phenyl Sephar-
3
40 nm was employed to monitor the decrease in NADPH concen-
ose 6 Fast Flow column (GE Healthcare), which was equilibrated
with five column volumes (CV) start buffer. The proteins were
eluted with potassium phosphate buffer (50 mm, pH 7) with a gra-
dient of 1.7m to 0m ammonium sulfate concentration. Active frac-
tions were pooled, and the buffer was changed to Tris·HCl buffer
tration during reduction catalyzed by the ADH. Benzaldehyde was
used as standard substrate because it is commercially available.
One unit of activity was defined as the amount of enzyme catalyz-
ing the oxidation of 1 mmol NADPH per minute under standard
conditions (258C, pH 7.0). The reduction assay mixture contained
980 mL substrate solution [substrate (10 mm) in Tris·HCl buffer
(
pH 9, 50 mm) by use of an Ultrafiltration membrane (Mr
0000 Da). After concentration, the protein solution was applied to
1
(pH 7.0, 100 mm), NADPH in distilled water (20 mm, 10 mL), enzyme
a Q Sepharose Fast Flow column (GE Healthcare) that had been
equilibrated with five CV Tris·HCl buffer (50 mm, pH 9). The column
was washed with the same buffer, and the proteins were eluted
with Tris·HCl buffer (50 mm, pH 9) containing NaCl (1m) with use
of a linear gradient from 0m to 1m NaCl. Active fractions were
pooled, equilibrated in potassium phosphate buffer [50 mm+NaCl
solution (10 mL)]. For the determination of the enzyme activity in
the oxidation reaction, the assay mixture contained 980 mL sub-
strate solution [substrate (10 mm) in Tris·HCl buffer (pH 9.0,
+
1
00 mm), NADP in distilled water (20 mm, 10 mL), enzyme solution
(10 mL)]. Reactions were started by addition of the enzyme solution
and measured over 1 min.
(
300 mm), pH 7.2] and applied to a Superdex 75 column (GE
Healthcare), which was equilibrated in potassium phosphate buffer
50 mm+NaCl (300 mm), pH 7.2]. Resulting fractions were tested
Determination of pH and temperature optima: In order to obtain
the pH and temperature optima of the ADH activity, the standard
enzyme assay was performed with ethyl 4-chloroacetoacetate
(10 mm) at different temperatures or pH values instead of benzal-
dehyde. (With benzaldehyde as substrate, the determination of pH
[
for activity (NADPH-dependent reduction of CF -ketone). After
3
each purification step, the protein concentration was determined,
and samples were subjected to SDS-PAGE analysis.
&
ChemBioChem 2016, 17, 1 – 11
8
ꢀ 2016 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!